Hereditary Angioedema Market Report 2026
Download Free Sample Buy Now
Hereditary Angioedema Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Hereditary Angioedema Market Report 2026

Global Outlook – By Type (Hereditary Angioedema Type I, Hereditary Angioedema Type II), By Treatment Type (Prophylaxis, On-demand), By Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes), By Route Of Administration (Subcutaneous, Intravenous, Oral), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Hereditary Angioedema Market Overview

• Hereditary Angioedema market size has reached to $2.81 billion in 2025

• Expected to grow to $4.15 billion in 2030 at a compound annual growth rate (CAGR) of 8%

• Growth Driver: Rising Prevalence Of Rare Diseases Driving The Growth Of The Market Due To Increasing Demand For Specialized Treatments

• Market Trend: Innovative Oral Treatment Marks Breakthrough In Rare Disease Care

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hereditary Angioedema Market?

Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling in the skin, gastrointestinal tract, and airways due to C1 esterase inhibitor deficiency or dysfunction. It is caused by genetic mutations affecting the complement system, leading to excessive bradykinin production. HAE can be life-threatening if airway swelling occurs, requiring prompt treatment with C1 inhibitor replacement or bradykinin-targeted therapies.

The main types of hereditary angioedema are hereditary angioedema type I and hereditary angioedema type II. Angioedema Type I is the most common form of hereditary angioedema (HAE) caused by a deficiency of C1 esterase inhibitor (C1-INH), leading to uncontrolled bradykinin production and recurrent swelling episodes. Treatment for HAE is typically divided into prophylaxis and on-demand options, with different drug classes such as C1 esterase inhibitors, bradykinin receptor antagonists, kallikrein inhibitors, and other drug classes. These treatments are administered through various routes, including subcutaneous, intravenous, and oral methods, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Hereditary Angioedema Market Global Report 2026 Market Report bar graph

What Is The Hereditary Angioedema Market Size and Share 2026?

The hereditary angioedema market size has grown strongly in recent years. It will grow from $2.81 billion in 2025 to $3.04 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increasing clinical awareness of rare genetic disorders, availability of plasma-derived c1 esterase inhibitors, expansion of specialty treatment centers, improved diagnostic accuracy for hae, growing patient advocacy initiatives.

What Is The Hereditary Angioedema Market Growth Forecast?

The hereditary angioedema market size is expected to see strong growth in the next few years. It will grow to $4.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to expansion of novel oral and subcutaneous therapies, increasing investment in rare disease drug development, rising adoption of personalized medicine approaches, growth in genetic screening programs, improved long-term disease management strategies. Major trends in the forecast period include increasing adoption of targeted bradykinin therapies, rising use of prophylactic treatment regimens, growing focus on early genetic diagnosis, expansion of home-based self-administration therapies, enhanced patient-centric treatment approaches.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Hereditary Angioedema Market Segmentation

1) By Type: Hereditary Angioedema Type I, Hereditary Angioedema Type II

2) By Treatment Type: Prophylaxis, On-demand

3) By Drug Class: C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes

4) By Route Of Administration: Subcutaneous, Intravenous, Oral

5) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Hereditary Angioedema Type I: C1-Inhibitor Deficiency, Low C1-Inhibitor Levels

2) By Hereditary Angioedema Type II: Normal C1-Inhibitor Levels, Dysfunctional C1-Inhibitor, Genetic Mutations In SERPING1 Gene

What Is The Driver Of The Hereditary Angioedema Market?

The growing prevalence of rare diseases is expected to propel the growth of the hereditary angioedema market going forward. Rare diseases, also known as orphan diseases, refer to medical conditions that affect a small percentage of the population. The increasing prevalence of rare diseases is due to multiple factors, such as progress in medical research, changes in population demographics, and environmental impacts. Hereditary angioedema (HAE) is a significant rare disease, highlighting the need for specialized treatments and awareness due to its life-threatening swelling episodes. Its rarity and genetic nature make early diagnosis and targeted therapies essential for effective management and improved patient outcomes. For instance, in January 2025, according to the The American Cancer Society, a US-based professional organization, in 2025, an estimated 59,660 new cases of oral cavity and oropharyngeal cancer are expected to be diagnosed, and approximately 12,770 people are projected to die from these cancers. Therefore, the growing prevalence of rare diseases is driving the growth of the hereditary angioedema industry.

Key Players In The Global Hereditary Angioedema Market

Major companies operating in the hereditary angioedema market are Takeda Pharmaceutical Company Limited, CSL Limited, Sanofi S.A., Pharming Group N.V., BioCryst Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Intellia Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Astria Therapeutics Inc., Pharvaris N.V., Adverum Biotechnologies Inc., ADARx Pharmaceuticals Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Spark Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc.

Global Hereditary Angioedema Market Trends and Insights

Major companies operating in the hereditary angioedema market are developing innovative products, such as oral plasma kallikrein inhibitors, to provide more convenient and effective on-demand treatment options for patients. Oral plasma kallikrein inhibitors are drugs that block plasma kallikrein to prevent excessive bradykinin production, primarily used for treating hereditary angioedema. For instance, in September 2024, KalVista Pharmaceuticals, Inc., a US-based pharmaceutical company, announced that the FDA has accepted its new drug application (NDA) for sebetralstat. This investigational oral plasma kallikrein inhibitor is intended for the on-demand treatment of hereditary angioedema (HAE) attacks in both adult and pediatric patients aged 12 and older. Sebetralstat provides a new treatment approach by targeting and inhibiting plasma kallikrein activity. The acceptance of the NDA represents a major milestone toward potential approval and commercialization.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Hereditary Angioedema Market?

In July 2023, BioCryst Pharmaceuticals, Inc., a US-based biopharmaceutical company, partnered with Er-Kim Pharmaceuticals to commercialize ORLADEYO in Turkey. Through this partnership, BioCryst Pharmaceuticals, Inc. seeks to improve access to ORLADEYO (berotralstat) for hereditary angioedema patients in Turkey while strengthening its presence in the global rare disease market. Er-Kim Pharmaceuticals is a Turkey-based company focused on developing, manufacturing, and marketing high-quality medicines across various therapeutic areas.

Regional Outlook

North America was the largest region in the hereditary angioedema market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hereditary Angioedema Market?

The hereditary angioedema market consists of revenues earned by entities by providing services such as diagnosis and genetic testing, acute attack management, and long-term prevention. The market value includes the value of related goods sold by the service provider or included within the service offering. The hereditary angioedema market also includes sales of plasma-derived products, biologics, and therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hereditary Angioedema Market Report 2026?

The hereditary angioedema market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary angioedema industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Hereditary Angioedema Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.04 billion
Revenue Forecast In 2035 $4.15 billion
Growth Rate CAGR of 8.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment Type, Drug Class, Route Of Administration, Distribution channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Takeda Pharmaceutical Company Limited, CSL Limited, Sanofi S.A., Pharming Group N.V., BioCryst Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Intellia Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Astria Therapeutics Inc., Pharvaris N.V., Adverum Biotechnologies Inc., ADARx Pharmaceuticals Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Spark Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Hereditary Angioedema Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Hereditary Angioedema Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Hereditary Angioedema Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Hereditary Angioedema Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Bradykinin Therapies

4.2.2 Rising Use Of Prophylactic Treatment Regimens

4.2.3 Growing Focus On Early Genetic Diagnosis

4.2.4 Expansion Of Home-Based Self-Administration Therapies

4.2.5 Enhanced Patient-Centric Treatment Approaches

5. Hereditary Angioedema Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Homecare Providers

5.4 Diagnostic Laboratories

5.5 Research Institutions

6. Hereditary Angioedema Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hereditary Angioedema Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hereditary Angioedema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Hereditary Angioedema Market Size, Comparisons And Growth Rate Analysis

7.3. Global Hereditary Angioedema Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Hereditary Angioedema Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hereditary Angioedema Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hereditary Angioedema Market Segmentation

9.1. Global Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hereditary Angioedema Type I, Hereditary Angioedema Type II

9.2. Global Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prophylaxis, On-demand

9.3. Global Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes

9.4. Global Hereditary Angioedema Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Subcutaneous, Intravenous, Oral

9.5. Global Hereditary Angioedema Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.6. Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

C1-Inhibitor Deficiency, Low C1-Inhibitor Levels

9.7. Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Normal C1-Inhibitor Levels, Dysfunctional C1-Inhibitor, Genetic Mutations In SERPING1 Gene

10. Hereditary Angioedema Market Regional And Country Analysis

10.1. Global Hereditary Angioedema Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Hereditary Angioedema Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hereditary Angioedema Market

11.1. Asia-Pacific Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hereditary Angioedema Market

12.1. China Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hereditary Angioedema Market

13.1. India Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hereditary Angioedema Market

14.1. Japan Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hereditary Angioedema Market

15.1. Australia Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hereditary Angioedema Market

16.1. Indonesia Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hereditary Angioedema Market

17.1. South Korea Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hereditary Angioedema Market

18.1. Taiwan Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hereditary Angioedema Market

19.1. South East Asia Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hereditary Angioedema Market

20.1. Western Europe Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hereditary Angioedema Market

21.1. UK Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hereditary Angioedema Market

22.1. Germany Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hereditary Angioedema Market

23.1. France Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hereditary Angioedema Market

24.1. Italy Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hereditary Angioedema Market

25.1. Spain Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hereditary Angioedema Market

26.1. Eastern Europe Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hereditary Angioedema Market

27.1. Russia Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hereditary Angioedema Market

28.1. North America Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hereditary Angioedema Market

29.1. USA Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hereditary Angioedema Market

30.1. Canada Hereditary Angioedema Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hereditary Angioedema Market

31.1. South America Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hereditary Angioedema Market

32.1. Brazil Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hereditary Angioedema Market

33.1. Middle East Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hereditary Angioedema Market

34.1. Africa Hereditary Angioedema Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Hereditary Angioedema Market, Segmentation By Type, Segmentation By Treatment Type, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hereditary Angioedema Market Regulatory and Investment Landscape

36. Hereditary Angioedema Market Competitive Landscape And Company Profiles

36.1. Hereditary Angioedema Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Hereditary Angioedema Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Hereditary Angioedema Market Company Profiles

36.3.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.2. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Pharming Group N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. BioCryst Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Hereditary Angioedema Market Other Major And Innovative Companies

KalVista Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Intellia Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Astria Therapeutics Inc., Pharvaris N.V., Adverum Biotechnologies Inc., ADARx Pharmaceuticals Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Spark Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc.

38. Global Hereditary Angioedema Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hereditary Angioedema Market

40. Hereditary Angioedema Market High Potential Countries, Segments and Strategies

40.1 Hereditary Angioedema Market In 2030 - Countries Offering Most New Opportunities

40.2 Hereditary Angioedema Market In 2030 - Segments Offering Most New Opportunities

40.3 Hereditary Angioedema Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Hereditary Angioedema Market, Overview Of Key Products - Product Examples
  • Table 2: Global Hereditary Angioedema Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Hereditary Angioedema Market, Supply Chain Analysis
  • Table 4: Global Hereditary Angioedema Market, Major Raw Material Providers
  • Table 5: Global Hereditary Angioedema Market, Major Resource Providers
  • Table 6: Global Hereditary Angioedema Market, Major Manufacturers (Suppliers)
  • Table 7: Global Hereditary Angioedema Market, Major Distributors And Channel Partners
  • Table 8: Global Hereditary Angioedema Market, Key Technologies & Future Trends
  • Table 9: Global Hereditary Angioedema Market, Major Trends
  • Table 10: Global Hereditary Angioedema Market, Major End Users
  • Table 11: Global Hereditary Angioedema Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Hereditary Angioedema Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Hereditary Angioedema Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Hereditary Angioedema Market - TAM, US$ Billion, 2025
  • Table 15: Global Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Hereditary Angioedema Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Hereditary Angioedema Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Hereditary Angioedema Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Hereditary Angioedema Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Hereditary Angioedema Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Hereditary Angioedema Market - Company Scoring Matrix
  • Table 98: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 99: CSL Limited Financial Performance
  • Table 100: Sanofi S.A. Financial Performance
  • Table 101: Pharming Group N.V. Financial Performance
  • Table 102: BioCryst Pharmaceuticals Inc. Financial Performance
  • Table 103: Global Hereditary Angioedema Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Hereditary Angioedema Market, Competitive Dashboard
  • Table 105: Global Hereditary Angioedema Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 108: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

List Of Figures

    Figure 1: Global Hereditary Angioedema Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Hereditary Angioedema Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Hereditary Angioedema Market, Supply Chain Analysis
  • Figure 4: Global Hereditary Angioedema Market, Major Raw Material Providers
  • Figure 5: Global Hereditary Angioedema Market, Major Resource Providers
  • Figure 6: Global Hereditary Angioedema Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Hereditary Angioedema Market, Major Distributors And Channel Partners
  • Figure 8: Global Hereditary Angioedema Market, Key Technologies & Future Trends
  • Figure 9: Global Hereditary Angioedema Market, Major Trends
  • Figure 10: Global Hereditary Angioedema Market, Major End Users
  • Figure 11: Global Hereditary Angioedema Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Hereditary Angioedema Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Hereditary Angioedema Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Hereditary Angioedema Market - TAM, US$ Billion, 2025
  • Figure 15: Global Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Hereditary Angioedema Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Hereditary Angioedema Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type I, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Hereditary Angioedema Market, Sub-Segmentation Of Hereditary Angioedema Type II, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Hereditary Angioedema Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Hereditary Angioedema Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Hereditary Angioedema Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Hereditary Angioedema Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Hereditary Angioedema Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Hereditary Angioedema Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Hereditary Angioedema Market - Company Scoring Matrix
  • Figure 98: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 99: CSL Limited Financial Performance
  • Figure 100: Sanofi S.A. Financial Performance
  • Figure 101: Pharming Group N.V. Financial Performance
  • Figure 102: BioCryst Pharmaceuticals Inc. Financial Performance
  • Figure 103: Global Hereditary Angioedema Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Hereditary Angioedema Market, Competitive Dashboard
  • Figure 105: Global Hereditary Angioedema Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 108: Global, Hereditary Angioedema Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Hereditary Angioedema Therapeutics Market Report 2026 - Global Outlook – By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Route of Administr...

Angina Market Report 2026 - Global Outlook – By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Ot...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Biopsy Devices Market Report 2026 - Global Outlook – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, St...

Peripheral Arterial Disease Market Report 2026 - Global Outlook – By Treatment Type (Devices, Catheters, Drugs, Other Types), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By End User (Ho...

Hereditary Cancer Testing Market Report 2026 - Global Outlook – By Test Type (Multi Panel Test, Single-Site Genetic Test), By Indication (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user ...

Angioplasty Balloons Market Report 2026 - Global Outlook – By Product Type (Normal Balloons, Scoring Balloons, Drug-Eluting Balloons, Cutting Balloons), By Material (Non-Compliant, Semi-Compliant), By Application (Corona...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Frequently Asked Questions

The Hereditary Angioedema market was valued at $2.81 billion in 2025, increased to $3.04 billion in 2026, and is projected to reach $4.15 billion by 2030.

The global Hereditary Angioedema market is expected to grow at a CAGR of 8.0% from 2026 to 2035 to reach $4.15 billion by 2035.

Some Key Players in the Hereditary Angioedema market Include, Takeda Pharmaceutical Company Limited, CSL Limited, Sanofi S.A., Pharming Group N.V., BioCryst Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Intellia Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Astria Therapeutics Inc., Pharvaris N.V., Adverum Biotechnologies Inc., ADARx Pharmaceuticals Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Spark Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc. .

Major trend in this market includes: Innovative Oral Treatment Marks Breakthrough In Rare Disease Care. For further insights on this market. request a sample here

North America was the largest region in the hereditary angioedema market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us